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The ts49 mutation of vaccinia virus WR was mapped by marker rescue to the E11 gene encoding a 15-kDa polypeptide.
During synchronous infection of BSC40 cells with wild-type virus, immunoreactive E11 protein accumulated in parallel with
the onset of late protein synthesis. Immunoblotting of extracts of wild-type virions showed that the E11 protein was
encapsidated within the virus core. A normal temporal pattern of viral protein synthesis was observed in cells infected with
ts49 at the nonpermissive temperature (407) and normal-appearing ts49 progeny virions were observed by electron micros-
copy. Sequencing of the E11 gene of ts49 revealed a single amino acid substitution, Gly(66)Arg, in the mutant E11 polypeptide.
The steady-state level of E11 protein during ts49 infection was much lower than that observed during infection with wild-
type virus. This was the case at both the permissive and nonpermissive temperatures. We discuss two possible explanations
for the thermosensitive growth of ts49: (i) that virus infectivity requires a threshold level of active E11 protein or (ii) that
E11 function is conditionally essential. q 1996 Academic Press, Inc.
Genes essential for the replication of vaccinia virus tion of microscopically normal-appearing virions that are
noninfectious. Other normal ts mutations also map toin cell culture have been identified by classical genetic
constituent polypeptides of the virion. These include theapproaches involving the isolation and characterization
D2, D3, and I7 proteins (10, 11), for which no enzymaticof temperature-sensitive mutant viruses (1). A collection
activity has yet been demonstrated, and the F10 protein,of 72 ts mutants of vaccinia strain WR has been assigned
which is a serine–threonine protein kinase (12, 13). Mu-to 32 genetic complementation groups by Condit and
tations of each of these proteins result in defective as-co-workers (2). At least one isolate from each of the
sembly of new virus particles at the nonpermissive tem-complementation groups has been analyzed with respect
perature.to the pattern of viral protein and DNA synthesis under
There are nine complementation groups of normal tsnonpermissive growth conditions (3, 4). Mutants in 22
mutants from the Condit collection that have not yet beencomplementation groups exhibit a so-called ‘‘normal’’
mapped to specific vaccinia genes. In this paper, wephenotype, i.e., they display a wild-type pattern of DNA
present a molecular genetic and phenotypic analysis ofreplication and protein synthesis at the nonpermissive
the vaccinia ts49 mutant, the lone member of comple-temperature.
mentation group 8 (2). ts49 was obtained from R. ConditThe normal phenotype is suggestive of mutation of
and subjected to two rounds of plaque purification ina viral gene encoding a protein that functions in virion
BSC40 cells grown at 317 (permissive temperature) priorassembly or in establishing the next round of infection,
to amplification in monolayer cultures at 317. Stocks offor example, during the synthesis of early mRNAs by the
ts49 were tested for their ability to replicate in BSC40virion-encapsidated RNA polymerase. This notion has
cells at 31 and 407. Titration experiments showed thatbeen borne out by the mapping of ts mutations to individ-
plaque formation by wild-type virus was equivalent at 31ual vaccinia genes. Several normal mutations affect enzy-
and 407. In the case of ts49, the ratio of plaques formedmatic components of the virus particle with a role in early
at 40 to 317 was 1/10,000. A one-step growth experimenttranscription. Examples include the H4 protein, a subunit
was performed with wild-type and ts49 viruses at bothof the virion RNA polymerase (5, 6); the D6 protein, a
31 and 407. Cells were harvested at 2, 12, 24, and 48 hrsubunit of the early transcription initiation factor (7); and
after infection, and the production of infectious virus wasthe I8 protein, an RNA helicase (8, 9). At the nonpermis-
assayed by titration at 317 (Table 1). The yield of ts49sive temperature, these mutations result in the produc-
progeny at the permissive temperature was about half
of that of wild-type virus at each time point. No increase
in the titer over the 2-hr background was observed when1 To whom correspondence and reprint requests should be ad-
dressed. infection with ts49 was performed at the nonpermissive
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TABLE 1
One-Step Growth of ts49 Virus at Permissive and Nonpermissive Temperatures
Titer (PFU/ml)
Virus Temperature 2 hr 12 hr 24 hr 48 hr
WT 317 2 1 105 1 1 107 2 1 107 1 1 108
407 2 1 104 1 1 107 3 1 107 1 1 108
ts49 317 3 1 105 4 1 106 1 1 107 3 1 107
407 3 1 105 2 1 105 2 1 105 3 1 105
Note. BSC40 cells maintained at 31 or 407 were infected with WT or ts49 virus at an m.o.i. of 10. At the indicated times postinfection, cells were
harvested and titered by serial 10-fold dilution onto BSC40 cells at 317. Plaques were visualized at 2 days postinfection by staining with 0.1% crystal
violet in 20% ethanol.
temperature. Growth of wild virus did not vary with tem- rescue yielded recombinant wild-type progeny from indi-
vidual electroporated cells that were seeded onto theperature, as expected. Thus, the plaque phenotype of the
ts49 mutant was clearly attributable to a thermosensitive virgin monolayer; this was manifested as a plaque arising
defect in virus replication.
Viral protein synthesis was analyzed by pulse-labeling
synchronously infected cells with [35S]methionine. Cells
infected at a multiplicity of 10 with wild-type or ts49 virus
at 317 displayed the typical developmental pattern of vac-
cinia gene expression, i.e., the appearance of novel early
polypeptides at 2–4 hr postinfection, transition to the
synthesis of distinctive late proteins by 8 hr (these in-
clude the major structural protein precursors p4a and
p4b), and shut-off of host protein synthesis late in infec-
tion (Fig. 1, top). Identical transitions were observed in
cells infected with ts49 virus at 407; however, the onset
of late viral protein synthesis was accelerated relative to
that at 317 (Fig. 1, bottom). There was no apparent differ-
ence between the protein synthesis profiles of wild-type
and ts49 virus-infected cells at either growth temperature
(Fig. 1).
Virus morphogenesis was evaluated by electron mi-
croscopy of ts49-infected cells. Spherical immature parti-
cles and brick-shaped intracellular mature virions (IMV)
were evident in the cytoplasm at 24 hr postinfection.
Spherical and IMV forms were also observed in ts49-
infected cells at the nonpermissive temperature (not FIG. 1. Synthesis of viral proteins by ts49 during synchronous infec-
tion. Confluent BSC40 monolayers were infected with virus at an m.o.i.shown). ts49 IMV particles formed at 407 were micro-
of 10 at 317 (top) or 407 (bottom). The inoculum was removed after 30scopically similar to wild-type IMV. Aside from sporadic
min, and cells were washed once with DME medium and then overlaid‘‘half-moon’’ spherical particles observed at 407 (11), we
with fresh DME. At various times thereafter, the medium was removed,
found no evidence for the accumulation of aberrant viral and cells were washed with methionine-free DME and then overlaid
structures at either growth temperature. with methionine-free DME containing 30 mCi of [35S]methionine per
milliliter (800 Ci/mmol). After pulse-labeling for 30 min at 31 or 407,It was reported previously that ts49 could be restored
the medium was removed and cells were lysed in situ by the additionto temperature-independent growth by marker rescue
of 0.15 ml of a solution containing 0.065 M Tris–HCl, pH 6.8, 2% SDS,with a plasmid containing the entire HindIII E genomic
5% b-mercaptoethanol, 10% glycerol. Aliquots (15 ml) were heated at
fragment derived from wild-type virus (2). An annotated 1007 for 5 min and then electrophoresed through a 12% polyacrylamide
map of the 15.2-kb E fragment, which includes 12 viral gel containing 0.1% SDS. Autoradiographs of the gels are shown. The
time at which the pulse-labeling was initiated (hours after removal ofgenes (14), is shown in Fig. 2. We mapped the ts49 muta-
the virus inoculum) is indicated above each lane. The identity of thetion more precisely using an electroporation-based
infecting virus is noted above each set of time points. Uninfected cellsmethod for DNA-mediated marker rescue (6, 11). Cells
were pulse-labeled in parallel as a control (lane C). The positions and
infected with ts49 were electroporated with plasmid DNA sizes (in kDa) of prestained marker proteins are indicated to the left.
and plated onto uninfected cell monolayers maintained Two abundant viral late proteins, corresponding to virion precursors
p4a and p4b, are denoted by arrows to the right.at the nonpermissive temperature. Successful marker
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FIG. 2. Map of the genomic HindIII E fragment and subfragments used for marker rescue. Plasmid pHind-E contains the full 15.2-kb HindIII E
fragment of vaccinia WR cloned into pBR322 (21). A physical and genetic map of the viral DNA insert is shown. Protein encoding regions of the E
fragment (illustrated as boxed segments) are distinguished from noncoding regions (intervening line segments). Plasmid pE-Bam/Hind (21) contains
a 7.2-kb segment of the E fragment extending from the internal BamHI site to the right terminal HindIII site; an expanded map of this insert is
shown below that of the E fragment. Plasmid pE-Cla/Hind contains 5.4 kb of DNA from the right end of the E fragment (21). Other subclones were
constructed by insertion of gel-purified restriction fragments into the polylinker of pBS(0) (Stratagene). Restriction sites used in subcloning are
indicated by vertical arrows. Plasmids were named according to the restriction sites at the borders of the viral insert. Genes E10 and E11 are
oriented in a tail-to-tail fashion, with E10 transcribed in a rightward direction and E11 transcribed in the leftward direction. A DNA fragment containing
both the E10 and E11 genes was PCR-amplified from pHind-E using flanking oligonucleotide primers containing restriction sites for NdeI and NcoI,
respectively. The PCR reaction product was gel-purified and then cleaved into E10- and E11-containing fragments by treatment with NdeI and EcoRI
or with NcoI and ClaI. A 386-bp NdeI–EcoRI fragment containing the entire E10 coding sequence and a 100-bp segment from the 3* end of the
E11 gene was gel-purified and inserted into pET14b (Novagen) to generate pet-E10. A 409-bp NcoI–ClaI fragment containing the entire E11 ORF
and 25 bp from the 3* end of the E10 gene was purified and inserted into plasmid pET14b to generate pet-E11. The viral inserts were then transferred
to pBS(0) vector backgrounds. A Bgl II/EcoRI fragment was excised from pet-E10 and inserted into pBS(0) cut with BamHI/EcoRI to yield pE10. An
SphI/ClaI fragment of pet-E11 was inserted to into pBS(0) cut with SphI/AccI to yield plasmid pE11. DNAs used for marker rescue experiments
were prepared by alkaline lysis and purified using the Wizard Maxipreps DNA purification system (Promega).
from each infectious center. No infectious centers were cluded, therefore, that the genetic lesion of ts49 localized
to the E11 gene.observed when monolayers were seeded with ts49-in-
fected cells that had been electroporated without added The nucleotide sequence of the wild-type E11 gene of
the WR strain of vaccinia was identical to the publishedDNA (Fig. 3). Marker rescue was achieved by electropor-
ation with the pHind-E plasmid containing the entire wild- sequence of the E11 gene of the Copenhagen strain (14).
The E11 gene encodes a protein of 129 amino acids withtype HindIII E fragment, but not with plasmid pHind-F
containing the 13.2-kb wild-type HindIII F fragment (Fig. a predicted molecular mass of 14.9 kDa. The molecular
lesion of the ts49 virus was determined by sequencing3). Rescue was also obtained with a BamHI/HindIII sub-
clone corresponding to the right half of the E fragment individual plasmid clones of the ts49 E11 gene obtained
by PCR amplification of cytoplasmic DNA isolated fromand including genes E6 to O1, with a ClaI/HindIII sub-
clone containing genes E9 to O1, and with EcoRV/KpnI ts virus-infected cells. Four different E11 clones were
sequenced for ts49, each of which contained a singleand DraI/KpnI subclones that included only genes E10
and E11 and a portion of the O1 gene (Fig. 3). Final coding change (GGG to AGG) resulting in a Gly to Arg
substitution at position 66.assignment of the ts49 mutation was made by amplifying
the wild-type E10 and E11 coding sequences by PCR The DNA sequence of the E11 gene suggested that it
is would likely be expressed at late times during vacciniaand cloning them separately into pBS vectors. Plasmid
pE11 containing the complete E11 gene and only 25 bp infection. For example, the ATG codon of the E11 protein
is situated within a TAAATG sequence; the TAAAT motifof sequence from the E10 gene afforded marker rescue,
whereas a plasmid containing the entire E10 gene and is an essential component of a vaccinia late promoter,
and the close proximity of the TAAAT to the translationa 3* segment of the E11 gene did not (Fig. 3). We con-
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start site is common feature of late genes (15). Further-
more, the E11 gene contains two internal TTTTTNT motifs
that specify termination of early gene transcription. Such
motifs tend to be excluded from the coding sequence of
viral early genes, but are usually detected with late cod-
ing sequences because this signal is not recognized as
a terminator during late transcription (16).
The accumulation of E11 protein during synchronous
infection of BSC40 cells with wild-type vaccinia virus was
examined by Western blotting with anti-E11 serum (Fig.
4). The antibody was raised in rabbits immunized with FIG. 4. Expression of the E11 protein during virus infection. BSC40
monolayers were infected synchronously at 317 (left) or 407 (right) withHis-tagged E11 protein that had been expressed in bac-
wild type (WT) or ts49 virus. At the indicated times (hr) after removal ofteria and purified to near-homogeneity from soluble bac-
the inoculum, the cells were lysed in situ as described for the metabolicterial lysates under nondenaturing conditions (S. Wang
labeling experiments. Lysates (30-ml aliquots) were heated at 1007 for
and S. Shuman, unpublished). Whole-cell lysates of virus- 5 min and then electrophoresed through a 15% polyacrylamide gel
infected cells were resolved by SDS–PAGE; the proteins containing 0.1% SDS. Polypeptides were transferred electrophoretically
to an ECL nitrocellulose membrane (Amersham) that was then blockedwere transferred to membranes, which were probed with
in TBST buffer (10 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.1% Tween-the anti-E11 serum and visualized by ECL. A 15-kDa im-
20) containing 10% dry milk. Membranes were incubated for 1 hr at
munoreactive polypeptide was detectable at 4 hr postin- room temperature with anti-E11 rabbit serum diluted 1:4000 in TBST.
fection at 317; this species increased in abundance by 8 After removal of serum and washing with TBST, bound antibodies were
localized by incubation with HRP-conjugated secondary antibody usinghr and persisted at 12 and 16 hr postinfection (Fig. 4).
an ECL detection system according to the instructions of the manufac-No such immunoreactive polypeptide was detected in
turer (DuPont NEN). The two blots shown in the figure were exposeduninfected cells (Fig. 4, lane C). As anticipated, the immu-
simultaneously to film. The identity of the infecting virus is noted above
noreactive E11 protein made during virus infection mi- each set of time points. Lysates of uninfected cells were analyzed in
grated more rapidly during SDS–PAGE than the His- parallel as a control (lane C), as was a sample of recombinant His-
E11 protein (His-E11). The positions and sizes (in kDa) of prestainedtagged E11 polypeptide antigen used to prepare the anti-
protein markers are indicated to the left.
serum (Fig. 4, lane His-E11). Note that the infected cell
lysates analyzed by Western blotting were the very same
ones used in the metabolic labeling experiment shown
in Fig. 1. Hence, we can conclude that the appearance
of the immunoreactive E11 protein coincided with the
onset of late protein synthesis. Accumulation of E11 pro-
tein in cells infected with wild-type virus at 407 was of
earlier onset than that at lower temperature, consistent
with the pulse-labeling experiment showing that the tran-
sition to late protein synthesis was accelerated during
infection at 407.
Parallel analysis by Western blotting of cells infected
with ts49 revealed a much lower accumulation of E11
protein compared to that of wild-type virus-infected cells.
Remarkably, this was the case at both permissive and
nonpermissive growth temperatures (Fig. 4). Again, be-
cause the samples analyzed were the same ones shown
in Fig. 1, we can be confident that the lack of E11 protein
accumulation was not secondary to a global failure to
synthesize late viral proteins. This result raises interest-
ing questions about the basis for the temperature-sensi-
tive phenotype of ts49 that will be considered below.FIG. 3. Marker rescue of ts49. Electroporation-based marker rescue
Vaccinia genes that bear the ‘‘normal’’ class of ts muta-using supercoiled plasmid DNAs was performed as described (6, 11).
After 2 days of incubation at 407, the cells were stained with 0.1% crystal tions often encode proteins that are encapsidated in the
violet in order to visualize plaques formed from infectious centers. virus particle. In order to examine whether the E11 protein
Photographs of the stained monolayers are shown. The plasmid tested
is a virion component, we probed virion extracts by Westernin each marker rescue is indicated above the well. The ‘‘No DNA’’
blotting with anti-E11 serum. The polypeptide compositionscontrol entailed seeding the monolayers with virus-infected BSC40
cells that had been electroporated without added DNA. of the virion envelope fraction (consisting of material solubi-
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pearing IMV particles were present in the cytoplasm of
ts49-infected cells at the nonpermissive temperature.
The formation of microscopically normal but noninfec-
tious IMV particles has been documented for other tem-
perature-sensitive or conditional null mutations affecting
constituents of the virus core. These include the H4 sub-
unit of the virion RNA polymerase (6, 17), the I8 RNA
helicase (8), the D6 subunit of the vaccinia early tran-
scription factor (7), and the L4 DNA binding protein (18).
In addition, the Dales collection of ts mutants of vaccinia
IHD includes four isolates (category Q) that form mature
particles of normal appearance at the nonpermissive
FIG. 5. Association of E11 protein with virus cores. (A) Extracts of temperature (19). In only a few cases has the lack ofpurified wild-type virions were prepared as described (6, 11). The enve-
infectivity been correlated with a specific biochemicallope fraction refers to material solubilized by treatment of virions with
defect of the progeny particles, for example, the failure50 mM DTT and 0.5% NP-40. The virus core was extracted with buffer
containing 0.2% sodium deoxycholate (DOC). Material solubilized by to encapsidate sufficient RNA polymerase in the case
this treatment is referred to as the DOC supernatant (DOC-S) fraction. of conditional mutants in the H4 and D6 genes (17, 7).
The residual insoluble material is referred to as the DOC pellet (DOC- Additional insights into the role of the E11 protein in virusP). Aliquots (5 ml) of each fraction were analyzed by electrophoresis
infectivity should emerge once the ts49 virions assem-through a 15% polyacrylamide gel containing 0.1% SDS. Polypeptides
bled at the nonpermissive temperature are purified andwere visualized by staining with Coomassie blue. (B) Aliquots (5 ml) of
each virion fraction were electrophoresed through a 15% polyacryl- subjected to detailed biochemical analysis.
amide gel containing 0.1% SDS. A sample of recombinant His-E11 The finding that the level of E11 protein expression is
protein was analyzed in parallel. Polypeptides were transferred to nitro- much lower in ts49-infected cells at both permissive andcellulose membranes for immunoblotting with 1:4000 dilutions of either
nonpermissive temperatures raises intriguing questionspreimmune or anti-E11 sera. Immunoreactive protein was detected by
about the basis for the conditional growth phenotype. WeECL. The two blots shown in the figure were exposed simultaneously
to film. The source of the protein fraction is indicated above each lane. attribute the low steady-state level of ts49 E11 protein to
The location and sizes (in kDa) of marker proteins are shown to the the point mutation described herein. Formally, this can be
left of each panel. secondary to a decreased rate of E11 protein synthesis
(either because of impaired translation or lower steady-
state levels of E11 mRNA) or an enhanced rate of E11
lized by treatment with NP-40 and dithiothreitol), a deoxy- protein turnover. Although we have not measured these
cholate extract of virion cores (0.2% DOC supernatant), and parameters directly, we favor the latter hypothesis. Studies
the insoluble pellet fraction (DOC pellet) were examined by of other vaccinia ts mutants affecting the D2, D3, and B1
SDS–PAGE in order to monitor the integrity of the extraction genes provide ample precedent for an enhanced rate of
procedure (Fig. 5A). Virion proteins were partitioned in char- specific degradation of the mutated protein at both nonper-
acteristic fashion. Western blotting revealed immunoreac- missive and permissive temperatures (10, 20).
tive E11 protein in the DOC extract of virus cores and in Normal replication of ts49 at permissive temperature
the insoluble core fraction, but not in the envelope fraction despite the very low steady-state levels of E11 protein
(Fig. 5B). No reactive protein of this size was detected when argues that the amount of E11 made by wild-type virus
immunoblotting was performed with preimmune rabbit se- is in excess of what is required for virus infectivity, at
rum. As expected, the core-associated E11 protein mi- least at 317. Yet, this same low amount of E11 protein
grated more rapidly during SDS–PAGE than the recombi- clearly does not suffice at 407. Does this reflect a temper-
nant E11 protein containing the His tag (Fig. 5B). These ature-sensitive defect in the ts49 E11 protein, or does
data indicate that the E11 protein is a component of the the problem reside elsewhere? If the residual ts49 E11
vaccinia core. protein is functionally temperature-sensitive per se, then
In summary, we find that a single amino acid substitu- its activity would be reduced to a subthreshold level at
tion in the E11 protein accounts for the conditional the nonpermissive temperature. There is precedent in the
growth phenotype of ts49. The E11 gene product is a 15- case of the F10 protein kinase for temperature-sensitive
kDa protein that accumulates at late times during infec- replication of vaccinia virus being correlated with thermo-
tion with wild-type virus and becomes encapsidated labile enzymatic activity in vitro (13). Obviously, this issue
within the core of the infectious virion. In agreement with is difficult to evaluate in the present case without a de-
Condit’s original observations (4), we found the pattern monstrable biochemical activity for the E11 gene product.
of viral protein synthesis in ts49-infected cells to be indis- An alternative explanation of the conditional growth de-
tinguishable from that of wild-type virus, at least at the fect is that the level of active ts49 E11 protein does not
level of resolution afforded by SDS–PAGE analysis of vary with temperature, but rather the threshold level of
[35S]methionine-labeled proteins from whole-cell lysates. E11 required for infectivity is increased at 407. In this
case, it might be predicted that growth at 407 would beWe determined by electron microscopy that normal-ap-
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